Welcome to Markets Desk, your midday read on what's moving markets and why.
The trade war with Canada is drawing real blood in specific corners of the U.S. economy. Automakers and home builders are absorbing the sharpest pain, given their deep reliance on Canadian steel, lumber, and parts. Analysts caution the broad macro drag may be modest, but for these sectors, the tariff math is punishing and immediate.
On the other side of the border, Canadian businesses are sounding the alarm in starker terms. Executives are warning of a vortex of downward pressures as uncertainty tightens its grip on cross-border commerce. The Financial Times reports companies that built their operations around integrated North American supply chains are now scrambling to model scenarios they hoped they'd never have to run.
Meanwhile, with inflation showing signs of re-acceleration, investors are hunting for shelter. Vertex Pharmaceuticals is drawing attention from analysts who argue its pricing power insulates earnings from cost pressures in a way most companies simply cannot replicate. In an environment where real returns are getting squeezed, that kind of top-line durability commands a premium.
That's the tape. Markets Desk, signing off the floor.
